Effective measures for the secondary prevention of<unk>  polyendocrine syndrome (APS) include patient education and periodic screening. In APS the time interval between involvement of one endocrine organ to other endocrine/nonendocrine organ may take years. Thus, patient should be informed about signs and symptoms of commonly associated conditions/disorders with APS. In addition, periodic screening at an interval of 6-12 months should be done to detect the presence of any autoantibody such as antibodies against 21-hydroxylase or islet cells.
Autoimmune polyendocrine syndrome secondary prevention
Autoimmune polyendocrine syndrome primary prevention
Multiple endocrine neoplasia type 2 prevention
Sheehan's syndrome secondary prevention
Addison's disease secondary prevention
Hypopituitarism secondary prevention
Sheehan's syndrome medical therapy
Addison's disease medical therapy